PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19233181-0	2009	Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.	Celecoxib	51-60	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	0-19	
19233181-1	2009	BACKGROUND & AIMS: Variants in the cytochrome P450 2C9 (CYP2C9) gene are associated with impaired metabolism of celecoxib.	Celecoxib	116-125	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	39-58	
19233181-1	2009	BACKGROUND & AIMS: Variants in the cytochrome P450 2C9 (CYP2C9) gene are associated with impaired metabolism of celecoxib.	Celecoxib	116-125	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	60-66	
19233181-10	2009	CONCLUSIONS: The greater efficacy of high-dose celecoxib, compared with the low-dose, in preventing colorectal adenoma appears confined to individuals with slow metabolizer (CYP2C9*3) genotypes.	Celecoxib	47-56	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	174-180